Home › NDC Lookup › RxCUI directory › RxCUI 1551468

12 HR bupropion hydrochloride 90 MG / naltrexone hydrochloride 8 MG Extended Release Oral... — RxCUI 1551468

RxNorm drug concept · Semantic clinical drug
RxCUI 1551468 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1551468
Official name12 HR bupropion hydrochloride 90 MG / naltrexone hydrochloride 8 MG Extended Release Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asnaltrexone HCl 8 MG / buPROPion HCl 90 MG 12HR Extended Release Oral Tablet
FDA products mapped1
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Naltrexone and Bupropion: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It helps adults lose weight and keep it off when combined with a reduced-calorie diet and more physical activity. It is for adults with obesity, or overweight plus a weight-related...
  • You take it by mouth, morning and evening, and your prescriber raises the dose gradually over the first few weeks. Swallow the tablets whole and don’t cut, chew, or crush them. Avo...
  • Nausea is the most common, followed by constipation, headache, vomiting, dizziness, trouble sleeping, dry mouth, and diarrhea. Tell your doctor if they are bothersome. Call right a...
  • Not always. It should never be combined with MAOI antidepressants or other bupropion products, and it can block opioid pain, cough, or diarrhea medicines. It also affects several o...
📖 Read our full Naltrexone and Bupropion guide →

🕸️ Concept Web — How 12 HR bupropion hydrochloride 90 MG / naltrexone... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 12 HR bupropion hydrochloride 90 MG / naltrexone hydrochloride 8 MG Extended Release Oral Tablet RxCUI 1551468

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 5

    The active substance itself — no strength, form, or brand attached yet.

    • Bupropion 42347
    • Naltrexone 7243
    • Bupropion / naltrexone 1551467
    • Bupropion hydrochloride 203204
    • Naltrexone hydrochloride 105069
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Contrave 1551469
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Bupropion / naltrexone Extended Release Oral Tablet 1551466
    • Bupropion hydrochloride / naltrexone hydrochloride Extended Release Oral Tablet 2649250
    • Bupropion / naltrexone Oral Product 1551464
    • Bupropion / naltrexone Pill 1551465
    • Bupropion hydrochloride / naltrexone hydrochloride Oral Product 2660229
    • Bupropion hydrochloride / naltrexone hydrochloride Pill 2660303
    • Bupropion / naltrexone Extended Release Oral Tablet [Contrave] 1551471
    • Bupropion hydrochloride / naltrexone hydrochloride Extended Release Oral Tablet [Contrave] 2654526
    • +5 more in this family
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 18 of 23 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Bupropion hydrochloride 90 MG SCDC · 1551462
  • Naltrexone hydrochloride 8 MG SCDC · 1551463
  • Bupropion / naltrexone Extended Release Oral Tablet SCDF · 1551466
  • Bupropion hydrochloride / naltrexone hydrochloride Extended Release Oral Tablet SCDFP · 2649250
  • Bupropion / naltrexone Oral Product SCDG · 1551464
  • Bupropion / naltrexone Pill SCDG · 1551465
  • Bupropion hydrochloride / naltrexone hydrochloride Oral Product SCDGP · 2660229
  • Bupropion hydrochloride / naltrexone hydrochloride Pill SCDGP · 2660303

Brand-Name Concepts

📦 FDA Products & Package NDCs

1 product · 2 package NDCs
2 package NDCs map to RxCUI 1551468 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
51267-0890-07 7 TABLET, EXTENDED RELEASE in 1 BOTTLE (51267-890-07) Contrave Extended-Release Nalpropion Pharmaceuticals LLC 2021-01-14
51267-0890-99 120 TABLET, EXTENDED RELEASE in 1 BOTTLE (51267-890-99) Contrave Extended-Release Nalpropion Pharmaceuticals LLC 2014-10-22
Observed labelers: Nalpropion Pharmaceuticals LLC (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.